Table 6.
Effect of different treatments of ANM on liver serum markers profile
| Group | ALT (U/l) | AST (U/l) | ALP (U/l) | Bilirubin |
|---|---|---|---|---|
| Control | 45.0 ± 1.56e | 40.3 ± 1.53e | 63.7 ± 1.10d | 0.59 ± 0.02d,e |
| Vehicle control | 40.8 ± 1.18e | 39.4 ± 1.18e | 60.4 ± 1.13d | 0.61 ± 0.02d,e |
| CCl4 (1 ml/kg) | 490.4 ± 5.19a | 320.9 ± 3.68a | 298.3 ± 3.29a | 1.97 ± 0.01c |
| Silymarin + CCl4 | 96.7 ± 2.47d | 96.9 ± 2.31d | 108.2 ± 3.98c | 0.73 ± 0.01c |
| ANM (200 mg/kg) + CCl4 | 137.2 ± 2.13b | 166.8 ± 2.06b | 196.7 ± 3.68b | 1.02 ± 0.10b |
| ANM (400 mg/kg) + CCl4 | 101.4 ± 1.74c | 121.4 ± 2.74c | 168.6 ± 2.61c | 0.66 ± 0.08c,d |
| ANM (200 mg/kg) | 52.0 ± 3.99c,d | 51.7 ± 2.81d | 73.9 ± 2.75c | 0.60 ± 0.03d,e |
| ANM (400 mg/kg) | 41.24 ± 2.01e | 37.2 ± 1.01e | 62.2 ± 2.70d | 0.59 ± 0.01e |
Values expressed as means ± SD. Means ± SD with different superscript letter (a–e) within the column indicate significant difference (P < 0.01)